OxTalks will soon be transitioning to Oxford Events (full details are available on the Staff Gateway). A two-week publishing freeze is expected in early Hilary to allow all events to be migrated to the new platform. During this period, you will not be able to submit or edit events on OxTalks. The exact freeze dates will be confirmed as soon as possible.
If you have any questions, please contact halo@digital.ox.ac.uk
After having worked for two years at the Ministry of Health’s Blair Research Institute (now the National Institute for Health), on malaria research in the Zambezi Valley, Tim Freeman established Malair (Pvt) Ltd, a private consultancy company that operated from 1993 to 2000. Under sponsorship from EMNET (Pvt) Ltd, Freeman implemented the Gokwe Malaria Project, taking exclusive control of mosquito-net distribution in the district. In his project report, Freeman framed rural communities as largely ignorant of malaria, positioning himself as a necessary intermediary. Yet his motives were far beyond humanitarianism as he explicitly sought to turn Gokwe into a profitable market space for mosquito nets, treating them as commodities to be sold the same way pharmaceuticals sell drugs. In this talk, I will be drawing on this to speak about the blurred and often contested boundary between public health interventions and market profit. I argue that Freeman’s project exemplifies how malaria control has repeatedly been shaped by the entanglement of humanitarian rhetoric with market‑driven imperatives.